3,079
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Measurement in Saliva From Neurotypical Adults of Biomarkers Pertinent to Autism Spectrum Disorders

&
Article: FSO70 | Published online: 22 Oct 2015

References

  • Rosignol DA , FryeRE. Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front. Physiol.5, 150 (2014).
  • Ratajczak HV . Theoretical aspects of autism: biomarkers – a review. J. Immunotox.8(1), 80–94 (2011).
  • Jepson B . Changing the Course of Autism. Sentient Publications, Boulder CO, USA (2007).
  • Filipek PA , JuranekJ, NguyenMT, CummingsC, GargusJJ. Relative carnitine deficiency in autism. J. Autism Dev. Disord.34(6), 615–623 (2004).
  • Celestino-Soper PBS , ViolanteS, CrawfordELet al. A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. Proc. Natl Acad. Sci. USA109(21), 7974–7981 (2012).
  • Frye RE , RossignolDA. Treatments for biomedical abnormalities associated with autism spectrum disorder. Front. Pediatr.2(66), 1–16 (2014).
  • Mostafa GA , AL-Ayadhi. Reduced levels of plasma polyunsaturated fatty acids and serum carnitine in autistic children: relation to gastrointestinal manifestations. Behav. Brain Funct.11(4), 1–10 (2015).
  • Blatt GJ , FitzgeraldCM, GuptillJT, BookerAB, KemperTL, BaumanML. Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J. Autism Dev. Disord.31(6), 537–543 (2001).
  • Marrosu F , MarrosuG, RachelMG, BiggioG. Paradoxical reactions elicited by diazepam in children with classic autism. Funct. Neurol.2(3), 355–361 (1987).
  • Cochrane DM , SikogluEM, HodgeSMet al. Relationship among glutamine, γ-aminobutyric acid, and social cognition in autism spectrum disorders. J. Child Adoles. Psychopharmacol.25(4), 314–322 (2015).
  • Shanahan MR , VenturiniAJ, DaissJLet al. Peptide diagnostic markers for human disorders. European Patent Application, Ep 0 969 015 A2, 05 January 2000.
  • Bashir S , AL-AyadhiL. Alterations in plasma dipeptidyl peptidase IV in autism: A pilot study. Neurol. Psychiat. Brain Res.20(2), 41–44 (2014).
  • Cieslinska A , Sienkiewicz-SzlapkaE, WasilewskaJet al. Influence of candidate polymorphisms on the dipeptidyl peptidase IV and μ-opiod receptor genes expression in aspect of the β- casomorphin-7 modulation functions in autism. Peptides65, 6–11 (2015).
  • Cass H , GringrasP, MarchJet al. Absence of urinary opioid peptides in children with autism. Arch. Dis. Child.93(9), 745–750 (2008).
  • Shattock P , WhiteleyP. Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin. Ther. Targets6(2), 175–183 (2002).
  • Warren RP , YonkJ, BurgerRW, OdellD, WarrenWL. DR-positive T-cells in autism: Association with decreased plasma levels of the complement C4B protein. Neuropsychobiology31(2), 53–57 (1995).
  • Warren RP , SinghVK, ColePet al. Increased frequency of the null allele at the complement C4B locus in autism. Clin. Exp. Immunol.83(3), 438–440 (1991).
  • Kunkel SL , WardPA, CaporaleLH, VogelC-W. The complement system. In: Immunology III. BellantiJA ( Ed.). WB Saunders Co., PA, USA, 106–116 (1985).
  • Mostafa GA , ShehabAA. The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children. J. Neuroimmunol.223(1–2), 115–119 (2010).
  • Goines PE , CroenLA, BraunschweigDet al. Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: a case-control study. Molec. Autism2(13), 1–11 (2011).
  • Ibrahim S , El-WaleelyT, ZakariaN, IsmailR. A study of serum interleukin-12 in a sample of autistic children in Egypt. Egyptian J. Psychiatry36(2), 81–87 (2015).
  • Xu N , LiX, ZhongY. Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders. Mediators Inflam.2015, 1–10 (2015).
  • Curin JM , TerzicJ, PetkovicZB, ZekanL, TerzicIM, SusnjaraIM. Lower cortisol and higher ACTH levels in individuals with autism. J. Autism Dev. Disord.33(4), 443–448 (2003).
  • Selmaoui B , TouitouY. Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: a study of three different 24-h cycles over six weeks. Life Sci.73(26), 3339–3349 (2003).
  • Corbett BA , MendozaS, WegelinJA, CarmeanV, LevineS. Variable cortisol circadian rhythms in children with autism and anticipatory stress. J. Psychiatry Neurosci.33(3), 227–234 (2008).
  • Spratt EG , NicholasJS, BradyKTet al. Enhanced cortisol response to stress in children in autism. J. Autism Dev. Disord.42(1), 75–81 (2012).
  • Putnam SK , LopataC, ThomeerML, VolkerMA, RodgersJD. Salivary cortisol levels and diurnal patterns in children with autism spectrum disorder. J. Dev. Physical Disabil.27(4), 453–465 (2015).
  • Corbett BA , SimonD. Adolescence, stress and cortisol in autism spectrum disorders. OA Autism1(1), 1–6 (2013).
  • Melke J , Goubran-BotrosH, ChastePet al. Abnormal melatonin synthesis in autism spectrum disorders. Mol. Psychiatry13(1), 90–98 (2008).
  • Novakova M , PacltI, PtacekR, KuzelovaH, HajekI, SumovaA. Salivary melatonin rhythm as a marker of the circadian system in healthy children and those with attention-deficit/hyperactivity disorder. Chronobiol. Int.28(7), 630–637 (2011).
  • Sanchez de la Peña S . The feed-sideward of cephalo-adrenal immune interactions. Chronobiologia20(1–2), 1–52 (1993).
  • Schwichtenberg AJ , MalowBA. Melatonin treatment in children with developmental disabilities. Sleep Med. Clin.10(2), 181–187 (2015).
  • Tilford JM , PayakachatN, KuhlthauKAet al. Treatment for sleep problems in children with autism and caregiver spillover effects. J. Autism Dev. Disord. doi:10.1007/s10803-015-2507-5 (2015) ( Epub ahead of print).
  • Belmonte MK , CookEHJr, AndersonGMet al. Autism as a disorder of neural information processing: directions for research and targets for therapy. Molec. Psychiatry9(7), 646–663 (2004).
  • Whitaker-Azmitia PM . Behavioral and cellular consequences of increasing serotonergic activity during brain development. A role in autism?Int. J. Dev. Neurosci.23(1), 75–83 (2005).
  • Adamsen D , RamaekersV, HoHTBet al. Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene. Molec. Autism5(43), 1–11 (2014).
  • Rose'Meyer R . A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders. Molec. Autism4(37), 1–16 (2013).
  • Montoya ER , TerburgD, BosPA, van HonkJ. Testosterone, cortisol, and serotonin as key regulators of social aggression: A review and theoretical perspective. Motiv. Emot.36, 65–73 (2012).
  • Takagishi H , TakahashiT, InukaiKet al. Salivary testosterone levels and autism-spectrum quotient in adults. Neuroendocrin. Let.31(6), 101–105 (2010).
  • Baron-Cohen S , AuyeungB, Norgaard-PedersenBet al. Elevated fetal steroidogenic activity in autism. Molec. Psychiatry20, 369–376 (2015).
  • Auyeung B , Baron-CohenS, AshwinE, KnickmeyerR, TaylorK, HackettG. Fetal testosterone and autistic traits. Br. J. Psychology100, 1–22 (2009).
  • Baron-Cohen S . The extreme male brain theory of autism. Trends Cogn. Sci.6(6), 248–254 (2002).
  • Krahn TM , FentonA. The extreme male brain theory of autism and the potential adverse effects for boys and girls with autism. J. Bioeth. Inquiry9(1), 93–103 (2012).
  • Larsen FV , LaiM-C, WagnerAP, MRC AIMS Consortium, Baron-CohenS, HollandAJ. Testing the ‘Extreme Female Brain’ theory of psychosis in adults with autism spectrum disorder with or without co-morbid psychosis. PLOS ONE10(6), e0128102 (2015).
  • Tordjman S , AndersonGM, McBridePAet al. Plasma androgens in autism. J. Autism Dev. Disord.25(3), 295–304 (1995).
  • Majewska MD , HillM, UrbanowiczEet al. Marked elevation of adrenal steroids, especially androgens, in saliva of prepubertal autistic children. Eur. Child Adolesc. Psychiatry23, 485–498 (2014).
  • James SJ , CutlerP, MelnykSet al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr.80, 1611–1617 (2004).
  • Wu G , FangY-Z, YangS, LuptonJR, TurnerND. Glutathione metabolism and its implications for health. J. Nutr.134, 489–492 (2004).
  • Geier DA , GeierMR. A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders. Horm. Res.66(4), 182–188 (2006).
  • Hansen RE , RothD, WintherJR. Quantifying the global cellular thiol-disulfide status. Proc. Natl Acad. Sci. USA106(2), 422–427 (2009).
  • Rose S , MelnykS, TrustyTAet al. Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism. Autism Res. Treat.2012, 986519 (2012).
  • Walsh WJ , UsmanA, TarpeyJ. Disordered metal metabolism in a large autism population. Presented at: American Psychiatric Association Annual Meeting. New Orleans, LA, USA, 5–10 May 2001.
  • Obrenovich ME , ShambergerRJ, LonsdaleD. Altered heavy metals and transketolase found in autistic spectrum disorder. Biol. Trace Elem. Res.144(1–3), 475–486 (2011).
  • Santos CRA , MartinhoA, QuintelaT, GoncalvesI. Neuroprotective and neuroregenerative properties of metallothioneins. IUBMB Life64(2), 126–135 (2012).
  • Pangborn JB . Nutritional Supplement Use for Autistic Spectrum Disorder. Autism Research Institute, CA, USA, 182 (2012).
  • Woods AG , WetieAGN, SokolowskaIet al. Mass specterometry as a tool for studying autism spectrum disorder. J. Molec. Psychiatry1(6), 1–10 (2013).
  • Wetie AGN , WormwoodKL, RussellS, RyanJP, CarieCC, WoodsAG. A pilot proteomic analysis of salivary biomarkers in autism spectrum disorder. Autism Res.8(3), 338–350 (2015).
  • Wormwood KL , AslebaghR, ChannaveerappaDet al. Salivary proteomics and biomarkers in neurology and psychiatry. Proteomics Clin. Appl. doi:10.1002/prca.201400153 (2015) ( Epub ahead of print).
  • Rashid MH , Al-JubouriRH. Assessment of serum and salivary oxidative stress biomarkers with evaluation of oral health status in a sample of autistic male children. J. Bagh College Dentistry23(3), 56–60 (2011).
  • Monjan AA . Stress in immunologic competence: studies in animals. In: Psychoneuroimmunology. AderR ( Ed.). Academic Press, NY, USA, 185–228 (1981).
  • Corbett BA , MendozaS, AbdullahM, WegelinJA, LevineS. Cortisol circadian rhythms and response to stress in children with autism. Psychoneuroendocrinology31(1), 59–68 (2006).
  • Sothern RB , Roitman-JohnsonB. Biological rhythms and immune function. In: Psychoneuroimmunlogy Volume 1 (3rd Edition). AderR, FeltenDL, CohenN ( Eds). Academic Press, CA, USA, 445–449 (2001).
  • Sothern RB . Clinical medicine. In: Introducing Biological Rhythms. KoukkariWL, SothernRB ( Eds). Springer, NY, USA, 426–525 (2006).
  • Katrib K , AdlouniAH, FerardG. Carnitine in human polymorphonuclear leukocytes, mononuclear cells, and platelets. Am. J. Clin. Nutr.46, 734–735 (1987).
  • Gleeson M . Dosing and efficacy of glutamine supplementation in human exercise and sport training. J. Nutr.138(10), S2045–S2049 (2008).
  • Stegink LD , FilerLJJr, BakerGL. Plasma amino acid concentrations in normal adults fed meals with added monosodium L-glutamate and aspartame. J. Nutr.113, 1851–1860 (1983).
  • Schmidt D , LoscherW. Plasma and cerebrospinal fluid γ-aminobutyric acid in neurological disorders. J. Neurol. Neurosurg. Psychiatry45(10), 931–935 (1982).
  • Songok EM , OseroB, MckinnonLet al. CD26/dipeptidyl peptidase IV (CD26/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected female sex workers. Virol. J.7, 343–349 (2010).
  • Hammond A , OllierW, WalportMJ. Effects of C4 null alleles and homoduplications on quantitative expression of C4A and C4B. Clin. Exp. Immunol.88(1), 153–168 (1992).
  • Chodorowska G . Plasma concentrations of IFN-gamma and TNF-alpha in psoriatic patients before and after local treatment with dithranol ointment. J. Eur. Acad. Dermatol. Venereology10(2), 147–151 (1998).
  • Wu HP , ShihCC, LinCY, HuaCC, ChuangDY. Serial increase of IL-12 response and human leukocyte antigen-DR expression in severe sepsis survivors. 10(2), 147–151 (1998).
  • Villette JM , BourinP, DoinelCet al. Circadian variations in plasma levels of hypophyseal adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J. Clin. Endocrinol. Metab.70(3), 572–577 (1990).
  • Rao ML , GrossG, StrebelBet al. Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia. Biol. Psychiatry35(3), 151–163 (1994).
  • Brigham MP , SteinWH, MooreS. The concentrations of cysteine and cystine in human blood plasma. J. Clin. Invest.39(110), 1633–1638 (1960).
  • Jones DP , CarlsonJL, SamiecPSet al. Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin. Chim. Acta275(2), 175–184 (1998).
  • Milnerowicz H , BizonA. Determination of metallothionein in biological fluids using enzyme-linked immunoassay with commercial antibody. Acta Biochim. Polonica57(10), 99–104 (2010).
  • Xie H , OnsongoG, PopkoJet al. Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol. Cell. Proteomics7(3), 486–498 (2008).
  • Brandtzaeg P . Salivary immunoglobulins. In: Human Saliva: Clinical Chemistsry and Microbiology (Volume II). TenovuoJO ( Ed.). CRC Press Inc., FL, USA, 3–11 (1989).